Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates.
Maiti A, Brown RE, Corn PG, Murthy R, Ganeshan DM, Tsimberidou AM, Subbiah V. Maiti A, et al. Among authors: ganeshan dm. Clin Genitourin Cancer. 2016 Apr;14(2):e187-93. doi: 10.1016/j.clgc.2015.11.004. Epub 2015 Nov 11. Clin Genitourin Cancer. 2016. PMID: 26684814 Free PMC article. No abstract available.
Diagnostic approach to hereditary renal cell carcinoma.
Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V. Gupta S, et al. Among authors: ganeshan dm. AJR Am J Roentgenol. 2015 May;204(5):1031-41. doi: 10.2214/AJR.14.13514. AJR Am J Roentgenol. 2015. PMID: 25905938 Review.
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM. Subbiah V, et al. Among authors: ganeshan dm. J Hematol Oncol. 2015 Jun 11;8:66. doi: 10.1186/s13045-015-0160-2. J Hematol Oncol. 2015. PMID: 26062823 Free PMC article.
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
Adashek JJ, Subbiah IM, Matos I, Garralda E, Menta AK, Ganeshan DM, Subbiah V. Adashek JJ, et al. Among authors: ganeshan dm. Trends Cancer. 2020 Mar;6(3):181-191. doi: 10.1016/j.trecan.2020.01.005. Epub 2020 Feb 6. Trends Cancer. 2020. PMID: 32101722 Free PMC article. Review.
Current update on gallbladder carcinoma.
Ganeshan D, Kambadakone A, Nikolaidis P, Subbiah V, Subbiah IM, Devine C. Ganeshan D, et al. Abdom Radiol (NY). 2021 Jun;46(6):2474-2489. doi: 10.1007/s00261-020-02871-2. Epub 2021 Jan 2. Abdom Radiol (NY). 2021. PMID: 33386907 Review.
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update.
Expert Panel on Urological Imaging; Ganeshan D, Khatri G, Ali N, Avery R, Caserta MP, Chang SD, De Leon AD, Gupta RT, Lyshchik A, Michalski J, Nicola R, Pierorazio PM, Purysko AS, Smith AD, Taffel MT, Nikolaidis P. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2023 May;20(5S):S246-S264. doi: 10.1016/j.jacr.2023.02.008. J Am Coll Radiol. 2023. PMID: 37236747
Current update on medullary thyroid carcinoma.
Ganeshan D, Paulson E, Duran C, Cabanillas ME, Busaidy NL, Charnsangavej C. Ganeshan D, et al. AJR Am J Roentgenol. 2013 Dec;201(6):W867-76. doi: 10.2214/AJR.12.10370. AJR Am J Roentgenol. 2013. PMID: 24261394 Review.
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update.
Expert Panel on Urological Imaging; Purysko AS, Nikolaidis P, Khatri G, Auron M, De Leon AD, Ganeshan D, Gore JL, Gupta RT, Shek-Man Lo S, Lyshchik A, Savage SJ, Smith AD, Taffel MT, Yoo DC, Lockhart ME. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2022 May;19(5S):S156-S174. doi: 10.1016/j.jacr.2022.02.015. J Am Coll Radiol. 2022. PMID: 35550799
99 results